| Literature DB >> 33953880 |
Mohsen Kalantari1, Hassan Sharifiyazdi1, Keramat Asasi1, Bahman Abdi-Hachesoo1.
Abstract
The objective was to investigate the multidrug resistance and presence of class 1 and 2 integrons in 300 Escherichia coli isolates obtained from 20 broiler farms during three rearing periods (one-day-old chicks, thirty-day-old chickens, and one day before slaughter) in Fars, South Iran. Results showed that 81.00%, 82.00%, and 85.00% of isolates were multidrug-resistant on the first day, thirty-day-old chickens, and one day before slaughter, respectively. Multidrug-resistant E. coli isolates were further examined for the presence of class 1 and 2 integrons using PCR assay. The existence of class 1 integron-integrase gene (intI1) was confirmed in 68.40%, 72.70%, and 60.90% of multidrug-resistant isolates from stage 1, stage 2, and stage 3 of the rearing period, respectively. The frequency of class 2 integron-integrase gene (intI2) during the first to the third stage of sampling was 2.60%, 25.50%, and 30.40%. Also, sequence analysis of the cassette arrays within class 1 integron revealed the presence of the genes associated with resistance for trimethoprim (dfrA), streptomycin (aadA), erythromycin (ereA), and orfF genes. The results revealed that percentages of antimicrobial resistance in E. coli isolates were significantly higher in the middle and end stages of the rearing period. In conclusion, widespread dissemination of class 1 integrons in all three stages and rising trends of class 2 integrons existence in E. coli isolates during the rearing period of broiler chickens could exacerbate the spread of resistance factors among bacteria in the poultry industry. Future research is needed to clarify its implication for human health.Entities:
Keywords: Broilers; Escherichia coli; Gene cassettes; Integrons; Multidrug resistance
Year: 2021 PMID: 33953880 PMCID: PMC8094138 DOI: 10.30466/vrf.2019.96366.2309
Source DB: PubMed Journal: Vet Res Forum ISSN: 2008-8140 Impact factor: 1.054
Antibiotic susceptibility test of E. coli isolates during a rearing period of broiler chickens (Stage1: day-old chicks, Stage 2: 30-day-old, and Stage 3: A day before slaughter).
|
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| ||
|
| 20.00 | 3.00 | 77.00 | 8.00 | 0.00 | 92.00 | 0.00 | 0.00 | 100.00 | |
|
| 22.00 | 2.00 | 76.00 | 8.00 | 0.00 | 92.00 | 0.00 | 0.00 | 100.00 | |
|
| 58.00 | 5.00 | 37.00 | 18.00 | 5.00 | 77.00 | 12.00 | 7.00 | 81.00 | |
|
| 24.00 | 30.00 | 46.00 | 15.00 | 7.00 | 78.00 | 3.00 | 7.00 | 90.00 | |
|
| 55.00 | 6.00 | 39.00 | 17.00 | 5.00 | 78.00 | 6.00 | 12.00 | 82.00 | |
|
| 23.00 | 31.00 | 46.00 | 54.00 | 11.00 | 35.00 | 52.00 | 17.00 | 31.00 | |
|
| 74.00 | 1.00 | 25.00 | 47.00 | 1.00 | 52.00 | 28.00 | 0.00 | 72.00 | |
|
| 98.00 | 0.00 | 2.00 | 88.00 | 6.00 | 6.00 | 85.00 | 6.00 | 9.00 | |
|
| 1.00 | 43.00 | 56.00 | 2.00 | 25.00 | 73.00 | 0.00 | 16.00 | 84.00 | |
|
| 63.00 | 20.00 | 17.00 | 49.00 | 23.00 | 28.00 | 57.00 | 10.00 | 33.00 | |
|
| 33.00 | 0.00 | 67.00 | 7.00 | 3.00 | 90.00 | 2.00 | 4.00 | 94.00 | |
|
| 33.00 | 0.00 | 67.00 | 6.00 | 0.00 | 94.00 | 4.00 | 2.00 | 94.00 | |
|
| 55.00 | 0.00 | 45.00 | 38.00 | 5.00 | 57.00 | 24.00 | 0.00 | 76.00 | |
|
| 83.00 | 1.00 | 16.00 | 51.00 | 5.00 | 44.00 | 74.00 | 5.00 | 21.00 | |
|
| 2.00 | 0.00 | 98.00 | 0.00 | 1.00 | 99.00 | 0.00 | 1.00 | 99.00 | |
|
| 2.00 | 53.00 | 45.00 | 0.00 | 48.00 | 52.00 | 1.00 | 64.00 | 35.00 | |
|
| 64.00 | 0.00 | 36.00 | 20.00 | 3.00 | 77.00 | 17.00 | 3.00 | 80.00 | |
S: susceptible, I: intermediate, R: resistant.
The number and percentage of integrase 1 (intI1), integrase 2 (intI1) genes, and co-existence of intI1 and intI2 genes in MDR E. coli isolated during a rearing period of broiler chickens (stage1: one-day-old chicks, stage 2: 30-day-old and stage 3: Aday before slaughter)
|
|
|
|
|
|
|---|---|---|---|---|
|
| 38 | 26 (68.40)a | 1 (2.60)a | 1 (2.60)a |
|
| 55 | 40 (72.70)a | 14 (25.50)b | 7 (12.70)a |
|
| 46 | 28 (60.90)a | 14 (30.40)b | 4 (8.70)a |
ab Columns with different superscripts have significant differences (p < 0.05).
Fig. 1A) PCR amplification of integrase 1 and 2 genes in E. coli isolated from broiler chickens. Lane 1: DNA marker, Lane 2: Negative control, Lane 3: Positive control of integrase 2, Lane 4: Positive control of integrase 1, Lane 5: Isolate positive for co-existence of both integrase genes, Lane 6: Isolate positive for integrase 1 gene, Lane 7: Isolate positive for integrase 2; B) PCR amplification of genes cassette in class 1 integrons. Bands with different sizes (~3200 bp, 1586 bp, 2097 bp, 1913 bp, and 1664 bp) harbor different resistance genes
Size and contents of gene cassettes and antibiotic resistance profile of sequenced MDR E. coli isolates
|
|
|
|
|
|---|---|---|---|
|
| 1586 |
| LP, TET, C, S, FM, SXT, E, NOR, ENR, T, NAL, CIP, FR, FF, N |
|
| 1586 |
| LP, TET, S, FM, SXT, E, AM, NOR, ENR, T, NAL, CIP, FF, N |
|
| 1664 |
| TET, C, S, FM, SXT, E, NOR, ENR, T, NAL, CIP, FR, N |
|
| 1913 |
| LP, TET, C, S, GM, FM, SXT, E, AM, NOR, ENR, T, NAL, CIP, FR, N |
|
| 1586 |
| LP, TET, C, S, FM, SXT, E, AM, NOR, ENR, T, NAL, CIP, FR, FF, N |
|
| 1664 |
| TET, C, S, FM, SXT, E, AM, NOR, ENR, T, NAL, CIP, N |
|
| 1586 |
| LP, TET, C, S, FM, SXT, E, AM, NOR, ENR, T, NAL, CIP, FR, FF, N |
|
| ~ 3200 |
| TET, C, S, GM, FM, SXT, E, AM, NOR, ENR, T, NAL, CIP, FR, N |
|
| 1913 |
| LP, TET, C, S, FM, SXT, E, AM, NOR, ENR, T, NAL, CIP, FR, N |
|
| 1586 |
| TET, C, S, GM, FM, SXT, E, NOR, ENR, T, NAL, FR, FF, N |
|
| 2097 |
| LP, TET, C, S, FM, SXT, E, NOR, ENR, T, NAL, CIP, FR, FF, N |
|
| 1913 |
| LP, TET, C, S, FM, SXT, E, NOR, ENR, T, NAL, CIP, FR, N |
|
| 1586 |
| LP, TET, C, S , FM, SXT, E, NOR, ENR, T, NAL, CIP, FR, FF, N |
|
| 2097 |
| TET, C, S, FM, SXT, E, NOR, ENR, T, NAL, CIP, FR, FF, N |
|
| 1586 |
| TET, S, FM, SXT, E, AM, NOR, ENR, T, NAL, CIP, FF, N |
|
| ~ 3200 |
| LP, TET, C, S, FM, SXT, E, AM, NOR, ENR, T, NAL, CIP, FR, FF, N |
NAL: Nalidixic acid, FM: Flumequine, CIP: Ciprofloxacin, ENR: Enrofloxacin, NOR: Norfloxacin, AM: Ampicillin, FR: Furazolidone, GM: Gentamicin, N: Neomycin, LP: Lincospectin, T: Tetracycline, TET: Oxytetracycline, C: Chloramphenicol, FF: Florfenicol, E: Erythromycin, S: Streptomycin, SXT: Trimethoprim-sulfamethoxazole.